Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Gastrointestinal Tolerability”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT02339207
What this trial is testing

First in Human Study of AL-335; Single Dose, Food Effect in Healthy Volunteers; Multiple Doses in Chronic Hepatitis C Genotype 1

Who this might be right for
Chronic Hepatitis C
Alios Biopharma Inc. 112
Testing effectiveness (Phase 2)Looking for participantsNCT07249463
What this trial is testing

Study Testing the Efficacy, Safety, and Tolerability of EDI048 in Cryptosporidium Infection Model in Healthy Adults

Who this might be right for
Cryptosporidiosis
Novartis Pharmaceuticals 80
Not applicableLooking for participantsNCT03530852
What this trial is testing

A 90 Day, Phase 3,Open Labeled Exploratory Study of RELiZORB

Who this might be right for
Short Bowel SyndromeMalabsorption
Boston Children's Hospital 32
Early research (Phase 1)Ended earlyNCT04117958
What this trial is testing

Study of AMG 199 in Subjects With MUC17-Positive Solid Tumors Including Gastric, Gastroesophageal Junction, Colorectal, and Pancreatic Cancers

Who this might be right for
MUC17-positive Solid Tumors
Amgen 58
Testing effectiveness (Phase 2)Ended earlyNCT04043455
What this trial is testing

Olorinab in Irritable Bowel Syndrome With Predominant Constipation (IBS-C) and Irritable Bowel Syndrome With Predominant Diarrhea (IBS-D)

Who this might be right for
Irritable Bowel Syndrome
Arena Pharmaceuticals 273
Testing effectiveness (Phase 2)Study completedNCT01275508
What this trial is testing

Safety and Tolerability of FITC-Adalimumab Administration During Confocal Laser Endomicroscopy of the Gut

Who this might be right for
Crohn's Disease
University of Erlangen-Nürnberg Medical School 25
Testing effectiveness (Phase 2)Active Not RecruitingNCT07222189
What this trial is testing

Investigate the Long-term Safety, Tolerability and Efficacy of Balinatunfib in Participants With Crohn's Disease or Ulcerative Colitis (SPECIFI-IBD-LTS)

Who this might be right for
Colitis UlcerativeCrohn's Disease
Sanofi 325
Not applicableLooking for participantsNCT06447168
What this trial is testing

A Study Observing Everyday Effectiveness and Safety of the Drug Elafibranor in Participants With Primary Biliary Cholangitis Who Are Receiving Ongoing Treatment

Who this might be right for
Primary Biliary Cholangitis
Ipsen 424
Testing effectiveness (Phase 2)Active Not RecruitingNCT04644068
What this trial is testing

Study of AZD5305 as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Malignancies

Who this might be right for
Ovarian CancerBreast CancerPancreatic Cancer+10 more
AstraZeneca 702
Early research (Phase 1)Looking for participantsNCT07094113
What this trial is testing

AMG 410 Alone and in Combination With Other Agents in Participants With KRAS Altered Advanced or Metastatic Solid Tumors

Who this might be right for
KRAS Altered Advanced or Metastatic Solid Tumors
Amgen 434
Large-scale testing (Phase 3)Study completedNCT00775528
What this trial is testing

Study Investigating a Delayed-Release Pancrelipase in Patients With Pancreatic Exocrine Insufficiency Due to Cystic Fibrosis

Who this might be right for
Cystic FibrosisPancreatic Exocrine Insufficiency
Solvay Pharmaceuticals 19
Early research (Phase 1)Study completedNCT07335198
What this trial is testing

Evaluate the Safety, Tolerability, Pharmacokinetics and Immunogenicity of Efimosfermin Alfa Administered as a Single Dose to Healthy Participants of Chinese, Japanese, and White/European Ancestry

Who this might be right for
Non-alcoholic Fatty Liver Disease
GlaxoSmithKline 30
Early research (Phase 1)Ended earlyNCT07029971
What this trial is testing

A First-in-Human Study of BB-TL1A-VIAL-HLE in Healthy Adults and People With Ulcerative Colitis

Who this might be right for
Ulcerative Colitis (UC)
Vial Australia Pty Ltd 16
Early research (Phase 1)Study completedNCT04242199
What this trial is testing

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of INCB099280 in Participants With Advanced Solid Tumors

Who this might be right for
Advanced Solid TumorMSI-H/dMMR TumorsCutaneous Squamous Cell Carcinoma+9 more
Incyte Corporation 182
Early research (Phase 1)Looking for participantsNCT06625775
What this trial is testing

Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors

Who this might be right for
Solid Tumor, AdultMetastatic Breast CancerAdvanced Breast Cancer+8 more
TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics) 392
Large-scale testing (Phase 3)Looking for participantsNCT06989437
What this trial is testing

Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue

Who this might be right for
CachexiaMetastatic Pancreatic Ductal Adenocarcinoma
Pfizer 982
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07391566
What this trial is testing

LPM6690176 in Combination With Chemotherapy and Bevacizumab in Metastatic Colorectal Cancer Patients With RAS Mutation

Who this might be right for
Metastatic Colorectal Cancer (mCRC)
Luye Pharma Group Ltd. 99
Large-scale testing (Phase 3)Study completedNCT01340937
What this trial is testing

V419 Given Concomitantly With Prevnar 13™ and RotaTeq™ (V419-006)

Who this might be right for
Bacterial InfectionsVirus Diseases
Merck Sharp & Dohme LLC 2,808
Testing effectiveness (Phase 2)UnknownNCT02128971
What this trial is testing

Compare the Gastrointestinal Tolerability of Ferrochel®, Sumalate®,Ferrous Fumarate, Ferrous Sulfate, Ferric Glycinate, and Placebo

Who this might be right for
Anemia
Albion 108
Early research (Phase 1)Active Not RecruitingNCT07350577
What this trial is testing

Evaluate the Safety, Tolerability, PK and PD of SAD of Intravenously Adminsterted ALTB-268 in Healthy Participants

Who this might be right for
Ulcerative Colitis (UC)
AltruBio Inc. 24
Next Page